查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030年全球過敏性免疫療法市場
市場調查報告書
商品編碼
1296882

2023-2030年全球過敏性免疫療法市場

Global Allergy Immunotherapy Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

胃腸道疾病的發病率越來越高，生命科學研究領域的投資和資金不斷增加，這些因素在預測期內促進了過敏免疫療法市場的成長。過敏免疫療法也被稱為低敏化。它是一種醫療手段，可以解決各種類型的過敏問題。在全球範圍內，各種類型的過敏症都有明顯的成長。藥物治療不足以解決和控制這些過敏性疾病的發生。因此，這是過敏免疫療法市場發展的一個主要驅動因素。使用這些治療方法能夠建立起對過敏物質的耐受性，並能夠改變疾病的進程。

分部前景

全球過敏症免疫療法市場根據治療方法、類型和配銷通路進行細分。根據類型，市場被分類為過敏性鼻炎、過敏性哮喘、食物過敏、藥物過敏和其他。由於全球範圍內哮喘的發病率越來越高，預計哮喘部分將佔據重要的市場佔有率。根據治療方法，市場被分為皮下免疫療法和舌下免疫療法。在預測期內，皮下免疫療法部分預計將保持相當大的成長率，因為它能有效地治療一些過敏症，如哮喘。此外，它是必須改變一個人的免疫系統以治愈其他過敏症發展的治療方案。根據配銷通路，市場被細分為醫院藥店、零售藥店和網上藥店。

過敏性鼻炎將是最大的部分

目錄

第一章：報告摘要

  • 當前行業分析和成長潛力展望
  • 研究方法和工具
  • 市場細分
    • 按領域分類
    • 按地區

第二章：市場概述和洞察力

  • 報告的範圍
  • 分析師的洞察力和當前的市場趨勢
    • 主要發現
    • 建議
    • 總結

第三章：競爭格局

  • 主要公司分析
  • Market Players
    • 概述
    • 財務分析
    • SWOT分析
    • 近期發展情況
  • 關鍵戰略分析

第四章：市場細分

  • 按類型分類的全球過敏性免疫療法市場
    • 過敏性鼻炎
    • 過敏性哮喘
    • 食物過敏
    • 藥物過敏
    • 其他類型
  • 全球過敏性免疫療法市場的治療方法
    • 皮下免疫療法
    • 舌下含服免疫療法
  • 按銷售管道分類的全球過敏性免疫療法市場
    • 醫院藥房
    • 零售藥店
    • 網上藥店

第五章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第六章：公司簡介

  • Aimmune Therapeutics, Inc.
  • ALK-Abello A/S
  • Allergopharma (A Division of Merck KGaA)
  • Allergy Therapeutics PLC
  • Biomay AG
  • CircassiaPharmaceuticals PLC
  • DBV Technologies SA
  • Desentum Oy
  • HAL Allergy Group
  • Jubilant Life Sciences, Ltd.
  • LetiPharma
  • Merck KGaA
  • Sandoz, Inc.
  • Stallergenes GREER, Ltd.
  • Torii Pharmaceutical Co, Ltd.
Product Code: OMR2027333

Global allergy immunotherapy market is anticipated to grow at a CAGR of 8.2% during the forecast period. Factor such as increasing awareness of allergies in patients is anticipated to propel the growth of the allergy immunotherapy industry. According to the World Allergy Organization, an increase in the pervasiveness of allergies has been witnessed and around 30% of the world population has allergic rhinitis. As per the Centers for Disease Control and Prevention (CDC), more than 8% of adults in the US suffer from sinusitis and hay fever. With the awareness created by these organizations; governments of different countries have sanctioned budgets for the R&D of allergy immunotherapy as an effective cure. Thus, this factor has a positive impact on the growth of the allergy immunotherapy market during the forecast period.

The factors such as the growing prevalence of gastrointestinal diseases, rising investments, and funding in the field of life science research boost the growth of the allergy immunotherapy market during the forecast period. Allergy immunotherapy is also known as hypo-sensitization. It is a type of medical treatment that allows for tackling various types of allergies. There has been significant growth in the various types of allergies across the globe. Pharmacotherapy is not enough to tackle and control the occurrence of these allergic disorders. Therefore, it is a major driving factor for the development of the allergy immunotherapy market. The use of these treatments enables building up the tolerance level against the allergic substances and enables altering the course of the disorders.

Segmental Outlook

The global allergy immunotherapy market is segmented based on treatment, type, and distribution channel. Based on type, the market is segmented into allergic rhinitis, allergic asthma, food allergy, drug allergy, and others. The asthma segment is expected to hold a significant market share due to the growing prevalence of asthma across the globe. Based on treatment, the market is bifurcated into subcutaneous immunotherapy and sublingual immunotherapy. The subcutaneous immunotherapy segment is expected to hold a considerable growth rate during the forecast period due to its effectiveness in treating several allergies such as asthma. Moreover, it is treatment options that have to alter one's immune system to cure the development of other allergies. Based on the distribution channel, the market is sub-segmented into hospital pharmacy, retail pharmacy, and online pharmacy.

Allergic Rhinitis will be the largest segment

Based on type, the market is segmented into allergic rhinitis, allergic asthma, food allergy, drug allergy, and others. The allergic rhinitis segment is expected to hold the largest market share in the allergy immunotherapy market. As per the Center for CDC around 8% of the total population is suffering from allergic rhinitis in the US. Therefore, the rising prevalence among adults and children is expected to propel the growth of the segment.

Regional Outlooks

The global Allergy Immunotherapy market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe market is anticipated to cater to a prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the Allergy Immunotherapy market.

The North American Region is anticipated to Hold a Significant Share in the Global Allergy Immunotherapy Market

Among these regions, the Asia-Pacific region is anticipated to account for a significant share of the Allergy Immunotherapy market during the forecast period. The growth of the allergy immunotherapy market in the region is primarily driven by factors such as the growing number of patients suffering from various types of allergies, and the growing prevalence of chronic diseases such as hypertension, asthma, allergies, and diabetes that fuel the growth of the allergy immunotherapy market. Along with it, the growing prevalence of allergic asthma, eczema, and food allergy improved healthcare facilities, growing funds from R&D, and the development of new products and therapy is also contributed to the market share in the region.

Market Players Outlook

The key players of the allergy immunotherapy market include Biomay AG, Aimmune Therapeutics, Inc., HAL Allergy Group, Allergopharma, Merck KGaA, Stallergenes Greer, Jubilant Life Sciences, Ltd., ALK-Abello A/S, Leti Pharma, and DBV Technologies. These market players are continuously adopting various strategies to expand their market share. For instance, in November 2018, Aimmune Therapeutics, Inc announced the closing of the $98 million equity investment by Nestle Health Science. The funding was provided to develop treatments for potentially life-threatening food allergies. Further, in October 2017, DBV Technologies entered into an R&D agreement for the treatment of birch allergies with standergness SA.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Market Players
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Allergy Immunotherapy Market by Type
    • 4.1.1. Allergic Rhinitis
    • 4.1.2. Allergic Asthma
    • 4.1.3. Food Allergy
    • 4.1.4. Drug Allergy
    • 4.1.5. Others
  • 4.2. Global Allergy Immunotherapy Market by Treatment
    • 4.2.1. Subcutaneous Immunotherapy
    • 4.2.2. Sublingual Immunotherapy
  • 4.3. Global Allergy Immunotherapy Market by Distribution Channel
    • 4.3.1. Hospital Pharmacy
    • 4.3.2. Retail Pharmacy
    • 4.3.3. Online Pharmacy

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Aimmune Therapeutics, Inc.
  • 6.2. ALK-Abello A/S
  • 6.3. Allergopharma (A Division of Merck KGaA)
  • 6.4. Allergy Therapeutics PLC
  • 6.5. Biomay AG
  • 6.6. CircassiaPharmaceuticals PLC
  • 6.7. DBV Technologies S.A.
  • 6.8. Desentum Oy
  • 6.9. HAL Allergy Group
  • 6.10. Jubilant Life Sciences, Ltd.
  • 6.11. LetiPharma
  • 6.12. Merck KGaA
  • 6.13. Sandoz, Inc.
  • 6.14. Stallergenes GREER, Ltd.
  • 6.15. Torii Pharmaceutical Co, Ltd.

LIST OF TABLES

  • 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL IMMUNOTHERAPY FOR ALLERGIC RHINITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL IMMUNOTHERAPY FOR ALLERGIC ASTHMA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL IMMUNOTHERAPY FOR FOOD ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL IMMUNOTHERAPY FOR DRUG ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL IMMUNOTHERAPY FOR OTHERS ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 8. GLOBAL SUBCUTANEOUS ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SUBLINGUAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 11. GLOBAL ALLERGY IMMUNOTHERAPY FOR HOSPITAL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL ALLERGY IMMUNOTHERAPY FOR RETAIL PHARMACY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL ALLERGY IMMUNOTHERAPY FOR ONLINE PHARMACY ALLERGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 18. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 21. EUROPEAN ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY TREATMENT, 2022 VS 2030 (%)
  • 3. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • 4. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL IMMUNOTHERAPY FOR ALLERGIC RHINITIS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL IMMUNOTHERAPY FOR ALLERGIC ASTHMA MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL IMMUNOTHERAPY FOR FOOD ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL IMMUNOTHERAPY FOR DRUG ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL IMMUNOTHERAPY FOR OTHERS ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL SUBCUTANEOUS ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL SUBLINGUAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ALLERGY IMMUNOTHERAPY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL ALLERGY IMMUNOTHERAPY FOR HOSPITAL PHARMACY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL ALLERGY IMMUNOTHERAPY FOR RETAIL PHARMACY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL ALLERGY IMMUNOTHERAPY FOR ONLINE PHARMACY ALLERGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. US ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. CANADA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. UK ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. FRANCE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. GERMANY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. ITALY ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. SPAIN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. ROE ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. INDIA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. CHINA ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. JAPAN ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ALLERGY IMMUNOTHERAPY MARKET SIZE, 2022-2030 ($ MILLION)